# Shailesh Maingi

> Shailesh Maingi is a Series A investor at Kineticos Life Sciences backing Biotechnology. See 3 investments, check sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: Kineticos Life Sciences
- Total investments: 3
- Last investment: May 2025
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/shaileshmaingi
- X (Twitter): https://twitter.com/MaingiShailesh
- Facebook: https://www.facebook.com/ShaileshMaingi

Shailesh Maingi is a Series A investor at Kineticos Life Sciences focused on Biotechnology and Wellness. Shailesh Maingi is the Founder & Exec Chair of Kineticos Ventures. He previously worked at Arranta Bio as a Board of Directors. Shailesh Maingi attended the University of North Carolina at Chapel Hill.

## Contacts

5 contacts available for Shailesh Maingi: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/shailesh-maingi-053a?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Wellness | 1 | 33% |
| Biopharma | 1 | 33% |
| Health Care | 1 | 33% |
| Pharmaceutical | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kincell Bio | Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. | $22M | Venture - Series Unknown | May 15, 2025 | https://kincellbio.com |
| Kincell Bio | Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. | $36M | Series A |  | https://kincellbio.com |
| Inceptor Bio | Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab andmanufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency. | $21M | Series A |  | https://www.inceptor.bio |

3 of 3 investments shown.

## Co-investors
- [NewSpring](https://shizune.co/investors/profile/newspring-capital) — VC Fund, 1 deal together

## About Kineticos Life Sciences

VC Fund · Morrisville, United States

Kineticos is a specialized management consulting firm serving the life science industry, located in North Carolina.

3 contacts available at Kineticos Life Sciences.

| Name | Title | Profile |
| --- | --- | --- |
| Abe Maingi | Vice President, Precision Medicine | — |
| Lloyd Payne | Venture Partner | — |
| Tom Pitler | President & COO | — |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Shailesh Maingi invest in?

Shailesh Maingi invests primarily in Biotechnology, Wellness and Biopharma startups, most often at Series A and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Shailesh Maingi?

Public channels for Shailesh Maingi include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Shailesh Maingi last invest?

The most recent investment recorded for Shailesh Maingi closed in May 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co